Close

Goldman Sachs Upgrades Omnicare (OCR) to Buy

September 11, 2014 6:51 AM EDT Send to a Friend
Goldman Sachs upgraded Omnicare (NYSE: OCR) from Neutral to Buy with a price target of $76.00. Analyst Stephan Stewart called ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login